Related Experiment Videos
Challenge of the two neural tumors: neuroblastoma and retinoblastoma
Insights
Neuroblastoma and retinoblastoma are challenging pediatric cancers often diagnosed at advanced stages. Early detection and treatment are crucial, especially in developing nations, as current therapies show limited efficacy in advanced cases.
Area of Science:
- Pediatric Oncology
- Cancer Research
Background:
- Neuroblastoma and retinoblastoma are significant pediatric malignancies.
- Many patients present with advanced-stage disease, posing treatment challenges.
Purpose of the Study:
- To retrospectively analyze treatment outcomes for neuroblastoma and retinoblastoma patients.
- To evaluate the efficacy of various chemotherapeutic agents and treatment strategies.
Main Methods:
- Retrospective analysis of 50 neuroblastoma and 29 retinoblastoma cases.
- Review of treatments including surgery, radiation, and chemotherapy (MTX, Ara-C, Thio-tepa).
Main Results:
- Long-term survival observed in neuroblastoma patients under 8 months old.
- Chemotherapy demonstrated limited impact on advanced-stage neuroblastoma and retinoblastoma.
- Retinoblastoma showed poor sensitivity to MTX and Ara-C; intrathecal Thio-tepa warrants further investigation.
Conclusions:
- Early diagnosis and prompt treatment are vital for improving outcomes in these challenging pediatric cancers.
- Current treatment modalities have limitations for advanced-stage disease, highlighting the need for novel therapeutic approaches.
- Focus on awareness and early intervention is critical, particularly for developing countries.
Abstract:
Fifty cases of neuroblastoma and 29 retinoblastoma patients who had additional chemotherapy were analyzed retrospectively. Male:Female ratio were 1:1 and 0.8:1, the ages ranged from birth to 14 years (4 +/- 3.42 year) for neuroblastoma, and one month to 5.5 years (2.4 +/- 1.4 year) for retinoblastoma. More than 70%-90% of them came in advanced stages. The treatment consisted of surgical resection, enucleation or exenteration if feasible. Radiation therapy and chemotherapy were given as specific and palliative measures. All of the neuroblastoma who were younger than 8 months old survived long-term. Various chemotherapeutic agents did not seem to effect the outcome of the advanced cases of these two diseases. The retinoblasts did not seem to be sensitive to MTX and Ara-C. Thio-tepa intrathecally seems to be worth trying. Since these two tumors are not sensitive to treatment and are still a great challenge to the developed countries, awareness of the diseases, early diagnosis and early treatment are appropriate approaches for the developing countries.